We are live on ! Find out more
GVAG

Great Valley Advisor Group Portfolio holdings

AUM $5.5B
1-Year Est. Return 20.56%
This Fund
S&P 500
This Quarter Est. Return
-13.74%
1 Year Est. Return
+20.56%
3 Year Est. Return
+61.82%
5 Year Est. Return
+67.54%
10 Year Est. Return
AUM
$1.82B
AUM Growth
+$105M
Cap. Flow
+$402M
Cap. Flow %
22.08%
Top 10 Hldgs %
18.45%
Holding
733
New
146
Increased
394
Reduced
109
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 10.16%
2 Healthcare 4.53%
3 Consumer Discretionary 3.54%
4 Financials 3.53%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNBS icon
651
Amplify Seymour Cannabis ETF
CNBS
$70.8M
$105K 0.01%
+1,332
New +$144K
BGY icon
652
BlackRock Enhanced International Dividend Trust
BGY
$512M
$67K ﹤0.01%
+13,185
New +$70.5K
DHY
653
Credit Suisse High Yield Credit Fund
DHY
$238M
$64K ﹤0.01%
+33,838
New +$68.1K
CERS icon
654
Cerus
CERS
$587M
$63K ﹤0.01%
11,973
+273
+2% +$1.36K
PRPO icon
655
Precipio
PRPO
$42.3M
$35K ﹤0.01%
+1,655
New +$37.5K
DHF
656
BNY Mellon High Yield Strategies Fund
DHF
$171M
$30K ﹤0.01%
+13,177
New +$32.7K
BDRX
657
Biodexa Pharmaceuticals
BDRX
$1.49M
0
ELVN icon
658
Enliven Therapeutics
ELVN
$3.78B
$26K ﹤0.01%
5,253
MDNA
659
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$23K ﹤0.01%
+19,500
New +$20.8K
ATIP
660
DELISTED
ATI Physical Therapy, Inc.
ATIP
$20K ﹤0.01%
+281
New +$24.9K
PSTV icon
661
Plus Therapeutics
PSTV
$26.4M
$18K ﹤0.01%
+90
New +$22.5K
OPGN
662
DELISTED
OpGen, Inc
OPGN
$14K ﹤0.01%
+126
New +$13.7K
TGB
663
Trekor Metals
TGB
$2.56B
$11K ﹤0.01%
10,000
XBIO icon
664
Xenetic Biosciences
XBIO
$6.05M
$8K ﹤0.01%
+1,060
New +$8.57K
CATX icon
665
Perspective Therapeutics
CATX
$332M
$4K ﹤0.01%
+1,200
New +$3.67K
NYMX
666
DELISTED
Nymox Pharmaceutical Corp
NYMX
$4K ﹤0.01%
+10,000
New +$9.2K
AUTO
667
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$4K ﹤0.01%
+10,925
New +$16.1K
AEM icon
668
Agnico Eagle Mines
AEM
$72.6B
-11,432
Closed -$699K
AME icon
669
Ametek
AME
$55.5B
-3,630
Closed -$487K
BALL icon
670
Ball Corp
BALL
$17B
-5,849
Closed -$526K
BCS icon
671
Barclays
BCS
$94.1B
-11,572
Closed -$93K
BDX icon
672
Becton Dickinson
BDX
$43.1B
-778
Closed -$200K
BLV icon
673
Vanguard Long-Term Bond ETF
BLV
$5.75B
-2,610
Closed -$239K
CIM
674
Chimera Investment
CIM
$1.05B
-14,631
Closed -$528K
CWB icon
675
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
-3,257
Closed -$252K

Similar funds

Great Valley Advisor Group's Q2 2022 Portfolio in Review

As of Q2 2022, Great Valley Advisor Group held 733 positions worth $1.82B, up 6.1% from $1.71B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Great Valley Advisor Group deployed $402M of net new capital in Q2 2022, opening 146 new positions and adding to 394 existing holdings. Its largest new stake was Pacer US Cash Cows 100 ETF: 375,852 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $18.5M trimmed.

  • Great Valley Advisor Group's largest Q2 2022 buy was Pacer US Cash Cows 100 ETF: 375,852 shares worth $16.2M.
  • Great Valley Advisor Group added most to First Trust Large Cap Core AlphaDEX Fund in Q2 2022, an estimated $30M increase.
  • Great Valley Advisor Group's biggest Q2 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $18.5M.
  • Great Valley Advisor Group fully exited First Trust Lunt US Factor Rotation ETF in Q2 2022, selling an estimated $27.6M.
  • Great Valley Advisor Group's ten largest holdings make up 18% of its $1.82B portfolio in Q2 2022.
  • Great Valley Advisor Group opened 146 new positions and closed 58 in Q2 2022.
  • Great Valley Advisor Group's portfolio value rose 6.1% quarter-over-quarter to $1.82B.

Based on Great Valley Advisor Group's 13F filing for Q2 2022, filed 19 Jul 2022.